ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
Protocol ID
BIOMEDE
Disease (Sub Disease)
Brain and Spinal Tumours
Diagnosis Stage
New diagnosis
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Collaborators
Innovative Therapies For Children with Cancer Consortium
Trial Status
Temporarily Closed
Study Type
Treatment
Phase
Phase 2
Age Eligibility
6 months to 25 years
International registry ID's
NCT02233049
Back to Registry
Study Title Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
Protocol ID BIOMEDE
Disease (Sub Disease) Brain and Spinal Tumours
Diagnosis Stage New diagnosis
Sponsor Gustave Roussy, Cancer Campus, Grand Paris
Collaborators Innovative Therapies For Children with Cancer Consortium
Links https://clinicaltrials.gov/ct2/show/NCT02233049
Trial Status Temporarily Closed
Trial Open Date 31/07/2018
Study Type Treatment
Phase Phase 2
Age Eligibility 6 months to 25 years
International registry ID's NCT02233049

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168